Maven Securities LTD Vera Therapeutics, Inc. Transaction History

Maven Securities LTD

  • $774 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$12.82 - $23.4 $823,556 - $1.5 Million
-64,240 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$17.8 - $28.06 $1.14 Million - $1.8 Million
64,240 New
64,240 $1.51 Million
Q3 2021

Nov 15, 2021
SELL
$13.71 - $30.6 $178,230 - $397,800
-13,000 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$11.5 - $19.97 $149,500 - $259,609
13,000 New
13,000 $178,000

Others Institutions Holding VERA

# of Institutions
184
Shares Held
55.1M
Call Options Held
134K
Put Options Held
156K
View Full List

About Vera Therapeutics, Inc.

VERA Quotes by TradingView
  • Ticker VERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,042,300
  • Market Cap $1.15B
  • Description
  • Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...
More about VERA
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email